---
title: "SKYWORTHDT today had a block trade of 4.54 million shares, with a transaction amount of 51.22 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/248125322.md"
description: "On July 11th, SKYWORTHDT had a block trade of 4.54 million shares, with a transaction amount of 51.22 million yuan, accounting for 25.71% of the total transaction amount for the day. The average transaction price was 11.28 yuan, which is a discount of 1.21% compared to the market closing price of 11.42 yuan, with the highest transaction price at 11.45 yuan and the lowest transaction price at 11.20 yuan"
datetime: "2025-07-11T08:53:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/248125322.md)
  - [en](https://longbridge.com/en/news/248125322.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/248125322.md)
generator: "portal-rs"
---

# SKYWORTHDT today had a block trade of 4.54 million shares, with a transaction amount of 51.22 million yuan

On July 11th, SKYWORTHDT had a block trade of 4.54 million shares, with a transaction amount of 51.22 million yuan, accounting for 25.71% of the total transaction amount for the day. The average transaction price was 11.28 yuan, which is a discount of 1.21% compared to the market closing price of 11.42 yuan, with the highest transaction price at 11.45 yuan and the lowest transaction price at 11.20 yuan

### Related Stocks

- [000810.CN](https://longbridge.com/en/quote/000810.CN.md)

## Related News & Research

- [15:00 ETSKYWORTH Sets New Quality/Performance Benchmark in Premium QD-Mini LED Art TVs with the Introduction of the C2 Canvas Art® TV](https://longbridge.com/en/news/297552429.md)
- [Chinese Pharma Companies Plan Hong Kong Listings](https://longbridge.com/en/news/297979501.md)
- [TP: Monthly Information Regarding Shares and Voting Rights](https://longbridge.com/en/news/297678327.md)
- [EBRD extends EUR 25 million revolving factoring facility to UniCredit Serbia under TFP](https://longbridge.com/en/news/297756600.md)
- [02:00 ETArgo Biopharma to Present Positive Phase II Updated Results of siRNA Therapeutic BW-20805 for HAE at Bradykinin Symposium 2026](https://longbridge.com/en/news/297995914.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**